Patents by Inventor Nozomu Ishida

Nozomu Ishida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150327581
    Abstract: In the present invention, an uncooked noodle prepared from a main raw material including at least wheat flour and starch is dried in humidified high-temperature heated air using heated air having a humidity of 80 mmHg-300 mmHg and a temperature of 110° C.-150° C. A heated-air-dried instant noodle is thereby obtained which has excellent restorability, and in which a dried noodle block has excellent strength.
    Type: Application
    Filed: January 16, 2014
    Publication date: November 19, 2015
    Inventors: Yoshiaki Nagayama, Nozomu Ishida, Hideki Komagata
  • Patent number: 9163874
    Abstract: Within a housing, a rotating shaft extends horizontally, and curved unbinding rods are secured to the rotating shaft at diagonally opposed positions to extend in radial directions. Within the housing, an inner wall surface is arranged along a circular arc whose center is aligned with an axis of the rotating shaft and whose diameter is slightly larger than a diameter of a circle drawn by rotating tips of the unbinding rods. A portion of the inner wall surface is formed as an unbinding surface having a circular arc cross sectional shape facing the unbinding rods with a small clearance. A mass of noodles for one meal charged into the housing from the inlet is sent in the counter-clockwise direction by the unbinding rods rotated at a high speed and is hit by the unbinding rods repeatedly to perform an effective unbinding function.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: October 20, 2015
    Assignee: SANYO FOODS CO., LTD.
    Inventors: Yoshiaki Nagayama, Nozomu Ishida
  • Publication number: 20120060702
    Abstract: Within a housing, a rotating shaft extends horizontally, and curved unbinding rods are secured to the rotating shaft at diagonally opposed positions to extend in radial directions. Within the housing, an inner wall surface is arranged along a circular arc whose center is aligned with an axis of the rotating shaft and whose diameter is slightly larger than a diameter of a circle drawn by rotating tips of the unbinding rods. A portion of the inner wall surface is formed as an unbinding surface having a circular arc cross sectional shape facing the unbinding rods with a small clearance. A mass of noodles for one meal charged into the housing from the inlet is sent in the counter-clockwise direction by the unbinding rods rotated at a high speed and is hit by the unbinding rods repeatedly to perform an effective unbinding function.
    Type: Application
    Filed: September 12, 2011
    Publication date: March 15, 2012
    Applicant: SANYO FOODS CO., LTD.
    Inventors: Yoshiaki NAGAYAMA, Nozomu ISHIDA
  • Patent number: 7994353
    Abstract: The present invention provides PPAR (peroxisome proliferator-activated receptor) activity regulators, which can be widely used for improving insulin resistance and preventing/treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high-blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis) and obesity.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: August 9, 2011
    Assignee: Ajinomoto Co., Inc.
    Inventors: Akiko Oonuki, Toshihiko Yoshimura, Katsumi Maezono, Yayoi Kawato, Hideyuki Tanaka, Naoyuki Fukuchi, Nozomu Ishida
  • Patent number: 7956041
    Abstract: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
    Type: Grant
    Filed: October 26, 2004
    Date of Patent: June 7, 2011
    Assignee: Ajinomoto Co., Inc.
    Inventors: Katsumi Maezono, Nozomu Ishida, Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Kageyama, Nobuo Kondo
  • Patent number: 7732637
    Abstract: The present invention provides an acylamide compound of the following formula (1), prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, therapeutic agent of metabolic syndromes, therapeutic agent of hypoadiponectinemia, therapeutic agent of hyperlipemia, preventive/therapeutic agent of diabetes, improving agent of impaired glucose tolerance, improving agent of insulin resistance, enhancing agent of insulin sensitivity, therapeutic agent of hypertension, preventive/therapeutic agent of vascular disorders, an anti-inflammatory agent, therapeutic agent of hepatic inflammation, therapeutic agent of fatty liver, therapeutic agent of hepatic fibrosis, therapeutic agent of liver cirrhosis, preventive/therapeutic agent of non-alcoholic/nonviral steatohepatitis (NASH) or non-alcoholic/nonviral fatty liver disease (NAFLD), or therapeutic agent of obesity, each of which has the above compounds as an active ingredient.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: June 8, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Katsumi Maezono, Toshihiko Yoshimura, Nozomu Ishida, Naoyuki Fukuchi, Toshihiro Hatanaka, Osamu Ikehara, Yayoi Kawato, Hideyuki Tanaka
  • Patent number: 7728158
    Abstract: The object of the present invention is to provide PPAR (peroxisome proliferator-activated receptor) activity regulators, which can be widely used for improving insulin resistance and preventing/treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high-blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis) and obesity. The present invention provides PPAR activity regulators which comprise an acylamide compound having the specific structure, prodrugs thereof, or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: June 1, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Akiko Oonuki, Toshihiko Yoshimura, Katsumi Maezono, Yayoi Kawato, Hideyuki Tanaka, Naoyuki Fukuchi, Nozomu Ishida
  • Publication number: 20100063151
    Abstract: The present invention provides acylamide compounds, prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, and therapeutic methods by administering the same.
    Type: Application
    Filed: November 18, 2009
    Publication date: March 11, 2010
    Applicant: Ajinomoto Co., Inc.
    Inventors: Katsumi MAEZONO, Toshihiko YOSHIMURA, Nozomu ISHIDA, Naoyuki FUKUCHI, Toshihiro HATANAKA, Osamu IKEHARA, Yayoi KAWATO, Hideyuki TANAKA
  • Publication number: 20090259061
    Abstract: The object of the present invention is to provide PPAR (peroxisome proliferator-activated receptor) activity regulators, which can be widely used for improving insulin resistance and preventing/treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high-blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis) and obesity. The present invention provides PPAR activity regulators which comprise an acylamide compound having the specific structure, prodrugs thereof, or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: March 5, 2009
    Publication date: October 15, 2009
    Applicant: AJINOMOTO, CO., INC.
    Inventors: Akiko OONUKI, Toshihiko YOSHIMURA, Katsumi MAEZONO, Yayoi KAWATO, Hideyuki TANAKA, Naoyuki FUKUCHI, Nozomu ISHIDA
  • Publication number: 20090012168
    Abstract: The present invention discloses an adiponectin inducer or secretagogue which comprises an amino acid(s) selected from the group consisting of leucine, isoleucine, valine, methionine, cystein, alanine and a mixture(s) thereof, and a therapeutic agent of hypoadiponectinemia, hyperlipemia, hypertension or vascular disorders or an anti-inflammatory agent, which comprises the adiponectin inducer or secretagogue.
    Type: Application
    Filed: June 28, 2007
    Publication date: January 8, 2009
    Applicant: AJINOMOTO CO., INC.
    Inventors: Katsumi MAEZONO, Naoyuki FUKUCHI, Nozomu ISHIDA, Akira MITSUI, Kenji TAKEHANA
  • Publication number: 20070282002
    Abstract: The present invention provides an acylamide compound of the following formula (1), prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, therapeutic agent of metabolic syndromes, therapeutic agent of hypoadiponectinemia, therapeutic agent of hyperlipemia, preventive/therapeutic agent of diabetes, improving agent of impaired glucose tolerance, improving agent of insulin resistance, enhancing agent of insulin sensitivity, therapeutic agent of hypertension, preventive/therapeutic agent of vascular disorders, an anti-inflammatory agent, therapeutic agent of hepatic inflammation, therapeutic agent of fatty liver, therapeutic agent of hepatic fibrosis, therapeutic agent of liver cirrhosis, preventive/therapeutic agent of non-alcoholic/nonviral steatohepatitis (NASH) or non-alcoholic/nonviral fatty liver disease (NAFLD), or therapeutic agent of obesity, each of which has the above compounds as an active ingredient.
    Type: Application
    Filed: August 7, 2007
    Publication date: December 6, 2007
    Applicant: AJINOMOTO CO. INC
    Inventors: Katsumi MAEZONO, Toshihiko Yoshimura, Nozomu Ishida, Naoyuki Fukuchi, Toshihiro Hatanaka, Osamu Ikehara, Yayoi Kawato, Hideyuki Tanaka
  • Publication number: 20070276041
    Abstract: The object of the present invention is to provide PPAR (peroxisome proliferator-activated receptor) activity regulators, which can be widely used for improving insulin resistance and preventing/treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high-blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis) and obesity. The present invention provides PPAR activity regulators which comprise an acylamide compound having the specific structure, prodrugs thereof, or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 25, 2007
    Publication date: November 29, 2007
    Applicant: AJINOMOTO, CO., INC.
    Inventors: Akiko Oonuki, Toshihiko Yoshimura, Katsumi Maezono, Yayoi Kawato, Hideyuki Tanaka, Naoyuki Fukuchi, Nozomu Ishida
  • Publication number: 20070072813
    Abstract: The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for preventing or treating of complications of diabetes mellitus, for reducing the weight, for preventing or treating the degeneration of pancreatic beta cells, for treating hyperinsulinemia and insulin resistance and diabetes type 1, in patients in need thereof by administering a pharmaceutical composition comprising a pyrazole-O-glycoside as defined in claim 1, or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 28, 2006
    Publication date: March 29, 2007
    Inventors: Frank Himmelsbach, Roland Maier, Peter Eickelmann, Leo Thomas, Edward Barsoumian, Klaus Dugi, Sabine Pinnetti, Regine Ritter, Ruediger Streicher, Koichi Fujita, Toshihiro Hatanaka, Nozomu Ishida, Katsumi Maezono, Koji Ohsumi
  • Publication number: 20050143424
    Abstract: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
    Type: Application
    Filed: October 26, 2004
    Publication date: June 30, 2005
    Applicant: AJINOMOTO CO. INC
    Inventors: Katsumi Maezono, Nozomu Ishida, Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Kageyama, Nobuo Kondo
  • Patent number: 6908905
    Abstract: The present invention relates to pyrazole derivatives represented by the following formulas and analogues thereof, which can be used for a therapeutic agent for diabetes.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: June 21, 2005
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Nozomu Ishida, Yoko Kageyama, Katsumi Maezono, Nobuo Kondo
  • Publication number: 20040110936
    Abstract: The present invention relates to pyrazole derivatives represented by the following formulas and analogues thereof, which can be used for a therapeutic agent for diabetes.
    Type: Application
    Filed: October 27, 2003
    Publication date: June 10, 2004
    Applicant: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Nozomu Ishida, Yoko Kageyama, Katsumi Maezono, Nobuo Kondo